Cost-effectiveness analyses of genetic and genomic diagnostic tests.

Cost-effectiveness analyses of genetic and genomic diagnostic tests.

Nat Rev Genet. 2018 Jan 22;:

Authors: Payne K, Gavan SP, Wright SJ, Thompson AJ

Developments in next-generation sequencing technologies have driven the clinical application of diagnostic tests that interrogate the whole genome, which offer the chance to diagnose rare inherited diseases or inform the targeting of therapies. New genomic diagnostic tests compete with traditional approaches to diagnosis, including the genetic testing of single genes and other clinical strategies, for finite health-care budgets. In this context, decision analytic model-based cost-effectiveness analysis is a useful method to help evaluate the costs versus consequences of introducing new health-care interventions. This Perspective presents key methodological, technical, practical and organizational challenges that must be considered by decision-makers responsible for the allocation of health-care resources to obtain robust and timely information about the relative cost-effectiveness of the increasing numbers of emerging genomic tests.

PMID: 29353875 [PubMed – as supplied by publisher]

Be the first to comment

Leave a Reply

Your email address will not be published.